服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-SOST mAbs [Blosozumab Biosimilar] (MABL-4468) | MABL-4468 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PCSK9 mAbs [Bococizumab Biosimilar] (MABL-4469) | MABL-4469 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-ADCYAP1/PACAP mAbs [Bocunebart Biosimilar] (MABL-4470) | MABL-4470 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TSLP mAbs [Bosakitug Biosimilar] (MABL-4471) | MABL-4471 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF7/CD27 mAbs [Boserolimab Biosimilar] (MABL-4472) | MABL-4472 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CTLA4/CD152 mAbs [Botensilimab Biosimilar] (MABL-4473) | MABL-4473 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL23A mAbs [Brazikumab Biosimilar] (MABL-4474) | MABL-4474 | ELISA, FACS, Functional assay, in vivo binding | G2, Lambda |
| Anti-Bet v 1 mAbs [Bremzalerbart Biosimilar] (MABL-4475) | MABL-4475 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CD3 mAbs [Brenetafusp Biosimilar] (MABL-4476) | MABL-4476 | ELISA, FACS, Functional assay, in vivo binding | na, Kappa |
| Anti-Staphylococcus aureus Toxin A mAbs [Berlimatoxumab Biosimilar] (MABL-4448) | MABL-4448 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL1A mAbs [Bermekimab Biosimilar] (MABL-4449) | MABL-4449 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ICAM1/CD54 mAbs [Bersanlimab Biosimilar] (MABL-4450) | MABL-4450 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-PDCD1/CD279/PD1;CD3E mAbs [Besufetamig Biosimilar] (MABL-4451) | MABL-4451 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-IL17A mAbs [Betinukibart Biosimilar] (MABL-4452) | MABL-4452 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDL1/CD274 mAbs [Betifisolimab Biosimilar] (MABL-4453) | MABL-4453 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-VEGFA mAbs [Bevacizumab Biosimilar] (MABL-4454) | MABL-4454 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL3RA/CD123;NCR1/NKP46/NKp46/LY94/CD335 mAbs [Bexatamig Biosimilar] (MABL-4455) | MABL-4455 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-STAB1 mAbs [Bexmarilimab Biosimilar] (MABL-4456) | MABL-4456 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CD74/HLA class II histocompatibility antigen gamma chain mAbs [Bezetabart Biosimilar] (MABL-445 | MABL-4457 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Clostridium difficile Toxin A mAbs [Bezlotoxumab Biosimilar] (MABL-4458) | MABL-4458 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn